Community Bank & Trust Waco Texas Has $345,000 Stake in CVS Health Corp (CVS)

Community Bank & Trust Waco Texas trimmed its stake in shares of CVS Health Corp (NYSE:CVS) by 64.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,388 shares of the pharmacy operator’s stock after selling 11,543 shares during the quarter. Community Bank & Trust Waco Texas’ holdings in CVS Health were worth $345,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently modified their holdings of the company. Beacon Financial Group raised its position in shares of CVS Health by 40.1% during the first quarter. Beacon Financial Group now owns 174,717 shares of the pharmacy operator’s stock worth $9,423,000 after acquiring an additional 50,024 shares during the last quarter. Highland Capital Management LLC raised its position in shares of CVS Health by 43.1% during the first quarter. Highland Capital Management LLC now owns 171,723 shares of the pharmacy operator’s stock worth $9,261,000 after acquiring an additional 51,693 shares during the last quarter. Rothschild Investment Corp IL raised its position in shares of CVS Health by 33.2% during the first quarter. Rothschild Investment Corp IL now owns 226,578 shares of the pharmacy operator’s stock worth $12,219,000 after acquiring an additional 56,467 shares during the last quarter. Gulf International Bank UK Ltd raised its position in shares of CVS Health by 0.6% during the first quarter. Gulf International Bank UK Ltd now owns 306,865 shares of the pharmacy operator’s stock worth $16,549,000 after acquiring an additional 1,970 shares during the last quarter. Finally, Oakbrook Investments LLC raised its position in shares of CVS Health by 65.5% during the first quarter. Oakbrook Investments LLC now owns 75,582 shares of the pharmacy operator’s stock worth $4,076,000 after acquiring an additional 29,920 shares during the last quarter. Institutional investors own 80.39% of the company’s stock.

NYSE CVS opened at $52.88 on Friday. CVS Health Corp has a one year low of $51.72 and a one year high of $82.15. The company has a market cap of $67.94 billion, a P/E ratio of 7.47, a price-to-earnings-growth ratio of 1.02 and a beta of 0.93. The company has a quick ratio of 0.64, a current ratio of 0.95 and a debt-to-equity ratio of 1.45.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.62 EPS for the quarter, topping the consensus estimate of $1.50 by $0.12. CVS Health had a positive return on equity of 16.80% and a negative net margin of 0.08%. The business had revenue of $61.65 billion during the quarter, compared to analysts’ expectations of $60.39 billion. During the same quarter last year, the firm posted $1.48 earnings per share. The firm’s revenue was up 34.8% on a year-over-year basis. As a group, research analysts predict that CVS Health Corp will post 6.83 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 3rd. Shareholders of record on Tuesday, April 23rd were paid a $0.50 dividend. The ex-dividend date of this dividend was Monday, April 22nd. This represents a $2.00 dividend on an annualized basis and a yield of 3.78%. CVS Health’s dividend payout ratio (DPR) is presently 28.25%.

In other news, Director Edward J. Ludwig acquired 4,000 shares of CVS Health stock in a transaction on Friday, March 1st. The stock was purchased at an average price of $58.27 per share, with a total value of $233,080.00. Following the completion of the purchase, the director now owns 5,378 shares of the company’s stock, valued at approximately $313,376.06. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP James David Clark sold 1,664 shares of the firm’s stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $58.14, for a total value of $96,744.96. Following the completion of the sale, the senior vice president now directly owns 8,557 shares of the company’s stock, valued at approximately $497,503.98. The disclosure for this sale can be found here. Insiders acquired 23,600 shares of company stock valued at $1,270,896 in the last three months. Insiders own 0.53% of the company’s stock.

A number of equities analysts have recently issued reports on CVS shares. ValuEngine downgraded CVS Health from a “sell” rating to a “strong sell” rating in a research report on Thursday, February 28th. CIBC restated a “market perform” rating on shares of CVS Health in a research report on Monday, April 15th. Oppenheimer downgraded CVS Health from an “outperform” rating to a “market perform” rating in a research report on Monday, April 15th. Argus decreased their target price on CVS Health from $100.00 to $80.00 and set a “positive” rating for the company in a research note on Monday, February 25th. Finally, SunTrust Banks decreased their target price on CVS Health to $85.00 and set a “buy” rating for the company in a research note on Thursday, February 21st. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $77.62.

TRADEMARK VIOLATION WARNING: This piece of content was posted by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.baseballdailydigest.com/news/2019/05/19/community-bank-trust-waco-texas-has-345000-stake-in-cvs-health-corp-cvs.html.

CVS Health Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

See Also: Technical Indicators – What is a Golden Cross?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.